Related Experiment Video

Updated: Jun 13, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Overview of the development and current use of CRM(197) conjugate vaccines for pediatric use

Henry R Shinefield1

  • 1Henryshinefield@aol.com

Vaccine
|May 11, 2010
PubMed

Insights

CRM(197) serves as a key carrier protein in pediatric glycoconjugate vaccines, offering safety and efficacy. Further research is needed to address conjugate interference, serotype expansion, and global vaccine access.

Area of Science:

  • Pediatric Vaccinology
  • Immunology
  • Protein Chemistry

Background:

  • Glycoconjugate vaccines are vital for preventing childhood diseases.
  • Existing vaccines demonstrate safety and effectiveness.
  • Several challenges remain, including conjugate interference and serotype coverage.

Purpose of the Study:

  • To evaluate CRM(197) as a carrier protein in pediatric vaccines.
  • To compare CRM(197) with other carrier proteins.
  • To identify future research directions for conjugate vaccines.

Main Methods:

  • Literature review of CRM(197) and other carrier proteins.
  • Analysis of conjugate interference and serotype expansion.
  • Assessment of vaccine effectiveness in special populations and developing countries.

Main Results:

  • CRM(197) is a well-established and effective carrier protein.
  • Comparison with other carriers highlights CRM(197)'s advantages.
  • Identified areas for future research include optimizing conjugate vaccines.

Conclusions:

  • CRM(197) is a valuable carrier protein for pediatric glycoconjugate vaccines.
  • Addressing conjugate interference and expanding serotype coverage are critical.
  • Further studies are essential for global conjugate vaccine implementation.

More Related Videos

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Vaccinations01:51

Vaccinations

Overview
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...